VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ICUI
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ICUIICU Medical, Inc.
$159.43$4.0B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksICUIQuarterly Financials

ICU Medical, Inc. (ICUI) Quarterly Financials

120+ quarters historyFree accessUpdated daily

ICU Medical, Inc. (ICUI) quarterly income statement — complete revenue, gross profit & net income history

ICUI Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue530.37M540.31M536.99M548.87M604.7M629.8M589.13M596.46M566.65M587.86M553.31M549.31M568.65M578.01M597.86M561M543.12M340.52M336.06M321.68M
Revenue Growth %-12.29%-14.21%-8.85%-7.98%6.71%7.14%6.47%8.58%-0.35%1.7%-7.45%-2.08%4.7%69.74%77.9%74.4%70.77%6.26%5.49%6.03%
Cost of Goods Sold357.28M338.18M336.11M340.8M394.59M402.55M384.28M389.03M381.41M416.27M369.39M356.98M376.61M403.07M411.46M393.41M374.3M213.03M208.27M198.15M
COGS % of Revenue67.36%62.59%62.59%62.09%65.25%63.92%65.23%65.22%67.31%70.81%66.76%64.99%66.23%69.73%68.82%70.13%68.92%62.56%61.97%61.6%
Gross Profit173.1M202.13M200.88M208.06M210.11M227.26M204.85M207.43M185.24M171.59M183.92M192.33M192.04M174.94M186.4M167.59M168.83M127.49M127.79M123.53M
Gross Margin %32.64%37.41%37.41%37.91%34.75%36.08%34.77%34.78%32.69%29.19%33.24%35.01%33.77%30.27%31.18%29.87%31.08%37.44%38.03%38.4%
Gross Profit Growth %-17.62%-11.06%-1.94%0.31%13.42%32.45%11.38%7.85%-3.54%-1.92%-1.33%14.76%13.75%37.22%45.86%35.67%49.83%6.35%12.17%16.23%
Operating Expenses142.42M176.9M187.16M197.48M197.22M189.57M196.62M199.74M195.9M183.77M161.07M189.57M182.65M175.17M186.86M167.64M210.99M103.67M89.41M89.06M
OpEx % of Revenue26.85%32.74%34.85%35.98%32.61%30.1%33.37%33.49%34.57%31.26%29.11%34.51%32.12%30.3%31.26%29.88%38.85%30.44%26.61%27.69%
Selling, General & Admin154.57M155.81M152.77M159.39M157.23M158.85M162.71M159.55M157.66M154.62M148.61M150.9M152.57M142.93M153.45M158.75M153.21M81.46M74.81M73.92M
SG&A % of Revenue29.14%28.84%28.45%29.04%26%25.22%27.62%26.75%27.82%26.3%26.86%27.47%26.83%24.73%25.67%28.3%28.21%23.92%22.26%22.98%
Research & Development21.28M21.09M21.25M21.87M23.29M22.36M21.03M23.39M21.84M22.41M20.87M22.3M19.76M23.45M23.11M22.56M23.87M13.17M12.24M11.38M
R&D % of Revenue4.01%3.9%3.96%3.98%3.85%3.55%3.57%3.92%3.85%3.81%3.77%4.06%3.48%4.06%3.86%4.02%4.4%3.87%3.64%3.54%
Other Operating Expenses-1000K01000K1000K1000K1000K1000K1000K1000K1000K-1000K1000K1000K1000K1000K-1000K1000K1000K1000K1000K
Operating Income30.68M25.23M13.72M10.59M12.89M37.69M8.24M7.69M-10.65M-12.18M22.85M2.76M9.39M-222K-467K-48K-42.16M23.82M38.38M34.47M
Operating Margin %5.78%4.67%2.55%1.93%2.13%5.98%1.4%1.29%-1.88%-2.07%4.13%0.5%1.65%-0.04%-0.08%-0.01%-7.76%7%11.42%10.72%
Operating Income Growth %138.04%-33.06%66.57%37.64%220.96%409.37%-63.96%178.7%-213.41%-5387.84%4993.58%5850%122.28%-100.93%-101.22%-100.14%-258.68%-11.82%50.33%76.26%
EBITDA80.7M79.57M64.52M60.25M62.33M90.7M63.84M63.01M44.87M44.98M296.6M60.26M65.09M56.59M58.17M66.51M10.98M46.96M60.63M56.63M
EBITDA Margin %15.22%14.73%12.02%10.98%10.31%14.4%10.84%10.56%7.92%7.65%53.6%10.97%11.45%9.79%9.73%11.86%2.02%13.79%18.04%17.61%
EBITDA Growth %29.47%-12.27%1.07%-4.38%38.92%101.67%-78.48%4.56%-31.07%-20.52%409.85%-9.4%493.01%20.51%-4.04%17.44%-77.47%-7.87%42.76%30.51%
D&A (Non-Cash Add-back)50.03M54.34M50.8M49.66M49.45M53.01M55.6M55.32M55.53M57.16M273.75M57.5M55.7M56.81M58.64M66.56M53.14M23.13M22.25M22.16M
EBIT30.68M6.45M15.75M56.74M14.36M34.41M9.36M7.12M-10.35M-9.97M11.74M2.97M10.88M-1.71M-156K-581K-41.16M23.7M38.09M34.99M
Net Interest Income16.49M-22.7M-19.81M-20.55M-25.79M-23.46M-24.68M-23.84M-23.77M-24.41M-24.18M-24.12M-22.52M-20.07M-17.81M-15.44M-13.05M-366K532K537K
Interest Income02.14M02.52M3.23M2.73M2.6M2.81M2.65M2.3M1.75M1.71M1.75M03.34M833K589K0700K700K
Interest Expense-16.49M24.84M19.81M23.07M29.02M26.19M27.29M26.65M26.42M26.71M25.92M25.83M24.27M20.07M21.15M16.27M13.64M366K168K163K
Other Income/Expense-35.26M-43.62M-17.77M25.93M-23.79M-29.47M-26.16M-27.23M-26.11M-24.5M-28.22M-25.62M-22.78M-21.23M-20.84M-16.81M-12.64M-488K-455K362K
Pretax Income-4.58M-18.39M-4.05M36.52M-10.91M8.22M-17.93M-19.53M-36.77M-36.68M-5.37M-22.86M-13.39M-21.45M-21.31M-16.85M-54.8M23.34M37.92M34.83M
Pretax Margin %-0.86%-3.4%-0.75%6.65%-1.8%1.3%-3.04%-3.27%-6.49%-6.24%-0.97%-4.16%-2.35%-3.71%-3.56%-3%-10.09%6.85%11.29%10.83%
Income Tax-34.71M-2.65M-658K1.18M4.57M32.05M15.05M1.87M2.7M-19.53M-12.6M-12.93M-3.58M-5.91M-8.1M-9.38M-16.73M3.41M6.84M6.43M
Effective Tax Rate %757.62%14.43%16.23%3.23%-41.9%389.98%-83.97%-9.59%-7.35%53.25%234.89%56.55%26.72%27.56%38.01%55.65%30.53%14.62%18.05%18.47%
Net Income30.13M-15.73M-3.4M35.34M-15.48M-23.83M-32.98M-21.41M-39.47M-17.15M7.24M-9.93M-9.81M-15.54M-13.21M-7.47M-38.07M19.93M31.08M28.4M
Net Margin %5.68%-2.91%-0.63%6.44%-2.56%-3.78%-5.6%-3.59%-6.97%-2.92%1.31%-1.81%-1.73%-2.69%-2.21%-1.33%-7.01%5.85%9.25%8.83%
Net Income Growth %294.7%33.97%89.7%265.08%60.79%-38.96%-555.69%-115.48%-302.27%-10.37%154.8%-32.91%74.23%-177.97%-142.5%-126.32%-260.41%-23.78%24.39%50.19%
Net Income (Continuing)30.13M-15.73M-3.4M35.34M-15.48M-23.83M-32.98M-21.41M-39.47M-17.15M7.24M-9.93M-9.81M-15.54M-13.21M-7.47M-38.07M19.93M31.08M28.4M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)1.20-0.64-0.141.43-0.63-0.97-1.35-0.88-1.63-0.710.30-0.41-0.41-0.65-0.55-0.31-1.610.911.431.31
EPS Growth %290.48%34.02%89.63%262.5%61.35%-36.62%-550%-114.63%-297.56%-9.23%154.55%-32.26%74.53%-171.43%-138.46%-123.66%-247.71%-24.79%23.28%48.86%
EPS (Basic)1.22-0.64-0.141.43-0.63-0.97-1.35-0.88-1.63-0.710.30-0.41-0.41-0.65-0.55-0.31-1.610.941.471.34
Diluted Shares Outstanding25.18M24.69M24.69M24.71M24.54M24.49M24.44M24.39M24.22M24.14M24.37M24.07M24.01M23.99M23.91M23.9M23.65M21.81M21.73M21.7M
Basic Shares Outstanding24.76M24.69M24.69M24.64M24.54M24.49M24.44M24.39M24.22M24.14M24.13M24.07M24.01M23.99M23.91M23.9M23.64M21.26M21.21M21.2M
Dividend Payout Ratio--------------------